Cargando…

Using alternatives to the car and risk of all-cause, cardiovascular and cancer mortality

OBJECTIVE: To investigate the associations between using alternatives to the car which are more active for commuting and non-commuting purposes, and morbidity and mortality. METHODS: We conducted a prospective study using data from 3 58 799 participants, aged 37–73 years, from UK Biobank. Commute an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panter, Jenna, Mytton, Oliver, Sharp, Stephen, Brage, Søren, Cummins, Steven, Laverty, Anthony A, Wijndaele, Katrien, Ogilvie, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Cardiac Risk Factors and Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241630/ https://www.ncbi.nlm.nih.gov/pubmed/29785956 http://dx.doi.org/10.1136/heartjnl-2017-312699

Ejemplares similares

Association of social relationships with incident cardiovascular events and all-cause mortality
por: Gronewold, Janine, et al.
Publicado: (2020)

Cardiovascular and type 2 diabetes morbidity and all-cause mortality among diverse chronic inflammatory disorders
por: Dregan, Alex, et al.
Publicado: (2017)

Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk
por: Jørstad, Harald T, et al.
Publicado: (2016)

Impact of changes in heart rate with age on all-cause death and cardiovascular events in 50-year-old men from the general population
por: Chen, Xiao-jing, et al.
Publicado: (2019)

The importance of early life family factors in the association between cardiovascular risk factors and early cardiovascular mortality
por: Kjøllesdal, Marte K R, et al.
Publicado: (2017)

Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease
por: Smith, Einar, et al.
Publicado: (2020)

Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank
por: Raisi-Estabragh, Zahra, et al.
Publicado: (2023)

Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality
por: Anderson, Simon G, et al.
Publicado: (2016)

Association between exercise habit changes and mortality following a cardiovascular event
por: Kang, Dong-Seon, et al.
Publicado: (2022)

Impact of COVID-19 pandemic on cardiovascular diseases hospitalisation, management and mortality in Switzerland
por: Maung, Ko Ko, et al.
Publicado: (2023)

Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease
por: Tessitore, Elena, et al.
Publicado: (2021)

Systematic screening for cardiovascular risk at pharmacies
por: Rohla, Miklos, et al.
Publicado: (2016)

Potential impact of a modest reduction in salt intake on blood pressure, cardiovascular disease burden and premature mortality: a modelling study
por: Aminde, Leopold Ndemnge, et al.
Publicado: (2019)

Nut consumption and incidence of seven cardiovascular diseases
por: Larsson, Susanna C, et al.
Publicado: (2018)

Low prevalence of ideal cardiovascular health in Peru
por: Benziger, Catherine P, et al.
Publicado: (2018)

COVID-19 and its impact on the cardiovascular system
por: Khawaja, Saud Ahmed, et al.
Publicado: (2021)

Short-term effects of air pollution on a range of cardiovascular events in England and Wales: case-crossover analysis of the MINAP database, hospital admissions and mortality
por: Milojevic, Ai, et al.
Publicado: (2014)

Cardiovascular risk after hospitalisation for unexplained syncope and orthostatic hypotension
por: Yasa, Ekrem, et al.
Publicado: (2018)

Longitudinal associations between loneliness, social isolation and cardiovascular events
por: Bu, Feifei, et al.
Publicado: (2020)

Convalescent troponin and cardiovascular death following acute coronary syndrome
por: Adamson, Philip D, et al.
Publicado: (2019)

Association between combat-related traumatic injury and cardiovascular risk
por: Boos, Christopher J, et al.
Publicado: (2022)

Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: the Tromsø Study 2015–2016
por: Nilsen, Amalie, et al.
Publicado: (2021)

The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment
por: Weng, Stephen F, et al.
Publicado: (2015)

Marginal role for 53 common genetic variants in cardiovascular disease prediction
por: Morris, Richard W, et al.
Publicado: (2016)

Cardiovascular risk assessment and treatment in chronic inflammatory disorders in primary care
por: Emanuel, G, et al.
Publicado: (2016)

Association of occupational exposures with cardiovascular disease among US Hispanics/Latinos
por: Bulka, Catherine M, et al.
Publicado: (2019)

Association of Life's Simple 7 and presence of cardiovascular disease in general Australians
por: Peng, Yang, et al.
Publicado: (2017)

Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors
por: Matthews, Anthony A, et al.
Publicado: (2021)

Mobile-phone text messaging to promote ideal cardiovascular health in women
por: Acevedo, Monica, et al.
Publicado: (2023)

Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk
por: Rao, Shishir, et al.
Publicado: (2023)

Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease
por: Graham, Fraser J, et al.
Publicado: (2023)

Angiotensin receptor blockers for prevention of cardiovascular disease: where does the evidence stand?
por: Fuchs, Flávio Danni, et al.
Publicado: (2015)

Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2016)

Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease
por: Akyea, Ralph Kwame, et al.
Publicado: (2019)

Outcomes of an integrated community-based nurse-led cardiovascular disease prevention programme
por: Connolly, S B, et al.
Publicado: (2017)

Sex differences in the association between childhood maltreatment and cardiovascular disease in the UK Biobank
por: Soares, Ana Luiza Gonçalves, et al.
Publicado: (2020)

Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and women
por: Miri, Yasmin, et al.
Publicado: (2021)

Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19
por: Norris, Tom, et al.
Publicado: (2022)

Pregnancy-related cardiovascular conditions and outcomes in a United States Medicaid population
por: Marschner, Simone, et al.
Publicado: (2022)

Differences of cardiovascular risk assessment in clinical practice using SCORE and SCORE2
por: Csenteri, Orsolya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u8cpon5fet6bnkmutq76gt95u4